Aspira Pathlab Diagnostics Ltd vs Aster Dm Quality Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 143.34 as of 29 Sep 10:20 . The P/E Ratio of Aspira Pathlab & Diagnostics Ltd changed from 43.3 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Aster DM Quality Care Ltd changed from 158 on March 2024 to 89.7 on March 2026 . This represents a CAGR of -9.00% over 6 years The Market Cap of Aspira Pathlab & Diagnostics Ltd changed from ₹ 31.91 crore on March 2024 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Aster DM Quality Care Ltd changed from ₹ 20437 crore on March 2024 to ₹ 34794 crore on March 2026 . This represents a CAGR of 9.27% over 6 years The revenue of Aspira Pathlab & Diagnostics Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Aster DM Quality Care Ltd for the Jun '26 is ₹ 1347 crore as compare to the Mar '26 revenue of ₹ 1218 crore. This represent the growth of 10.57% The ebitda of Aspira Pathlab & Diagnostics Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Aster DM Quality Care Ltd for the Jun '26 is ₹ 178.58 crore as compare to the Mar '26 ebitda of ₹ 260.58 crore. This represent the decline of -31.47% The net profit of Aspira Pathlab & Diagnostics Ltd changed from ₹ 0.05 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Aster DM Quality Care Ltd changed from ₹ 5152 crore to ₹ 29.28 crore over 9 quarters. This represents a CAGR of -89.95% The Dividend Payout of Aspira Pathlab & Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Aster DM Quality Care Ltd changed from 3818 % on March 2024 to 58.04 % on March 2026 . This represents a CAGR of -75.23% over 3 years .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
ASDL is a leading pathology specialist, with Pan-India presence.
It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results.

About Aster DM Healthcare Ltd

Aster DM Healthcare Limited was erstwhile established as 'Aster DM Healthcare Private Limited', a private limited company on 18 January, 2008.
On November 29, 2013.
The Company was converted into a public limited company and the name of the Company was changed to Aster DM Healthcare Limited. Aster DM Healthcare Limited is one of the leading healthcare player in the GCC and India.
Founded in 1987 by Dr. Azad Moopen, the Company has emerged as an integrated healthcare service organization that provides the complete circle of care to people through network of hospitals, clinics, labs and pharmacies, providing primary, secondary, tertiary to quaternary care to all segments of the population. Aster DM offer a diverse portfolio of specialised brands that serve patients in Primary, Secondary, Tertiary, and Quaternary Care, Healthcare Retailing, Diagnostic Laboratories, Digital Health, and Medical Education.

FAQs for the comparison of Aspira Pathlab & Diagnostics Ltd and Aster DM Quality Care Ltd

Which company has a larger market capitalization, Aspira Pathlab & Diagnostics Ltd or Aster DM Healthcare Ltd?

Market cap of Aspira Pathlab & Diagnostics Ltd is 129 Cr while Market cap of Aster DM Healthcare Ltd is 56,222 Cr

What are the key factors driving the stock performance of Aspira Pathlab & Diagnostics Ltd and Aster DM Healthcare Ltd?

The stock performance of Aspira Pathlab & Diagnostics Ltd and Aster DM Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aspira Pathlab & Diagnostics Ltd and Aster DM Healthcare Ltd?

As of October 25, 2026, the Aspira Pathlab & Diagnostics Ltd stock price is INR ₹126.05. On the other hand, Aster DM Healthcare Ltd stock price is INR ₹645.0.

How do dividend payouts of Aspira Pathlab & Diagnostics Ltd and Aster DM Healthcare Ltd compare?

To compare the dividend payouts of Aspira Pathlab & Diagnostics Ltd and Aster DM Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.